Seres Therapeutics (MCRB) director receives 6,500 stock options at $7.14 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Seres Therapeutics, Inc. director Dennis A. Ausiello received a grant of stock options covering 6,500 shares of common stock at an exercise price of $7.14 per share. The options vest and become exercisable on the earlier of July 8, 2027 or the day immediately prior to the first annual stockholder meeting occurring after July 8, 2026, and expire on July 7, 2036. Following this grant, he holds 6,500 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Ausiello Dennis A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 6,500 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 6,500 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Option shares granted: 6,500 shares
Exercise price: $7.14 per share
Expiration date: July 7, 2036
+1 more
4 metrics
Option shares granted
6,500 shares
Stock Option (right to buy) grant to director Dennis A. Ausiello on July 8, 2026
Exercise price
$7.14 per share
Conversion or exercise price for the 6,500 stock options granted
Expiration date
July 7, 2036
Expiration of the 6,500 stock options if not exercised earlier
Shares underlying options
6,500 shares
Each option represents the right to buy one share of common stock
Key Terms
Stock Option (right to buy), exercise price, vests and becomes exercisable, expiration date
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 7.1400"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vests and becomes exercisable financial
"The option vests and becomes exercisable on the earlier to occur of"
expiration date financial
"expiration_date: 2036-07-07T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did Seres Therapeutics (MCRB) director Dennis Ausiello report on this Form 4?
Director Dennis A. Ausiello reported a grant of stock options for 6,500 shares of Seres Therapeutics common stock at an exercise price of $7.14 per share as director compensation.
What is the exercise price of the new stock options reported for MCRB?
The granted stock options have an exercise price of $7.14 per share. This is the price at which Dennis A. Ausiello can purchase Seres Therapeutics common stock once the options vest.
When do Dennis Ausiello’s new Seres Therapeutics (MCRB) options vest?
The options vest on the earlier of July 8, 2027 or the day immediately prior to the first annual meeting of stockholders occurring after July 8, 2026, according to the grant terms.
How many Seres Therapeutics (MCRB) options does Dennis Ausiello hold after this transaction?
After this grant, Dennis A. Ausiello beneficially holds 6,500 stock options directly, each representing the right to acquire one share of Seres Therapeutics common stock upon exercise.
What is the expiration date of the Seres Therapeutics (MCRB) options granted to Dennis Ausiello?
The granted stock options expire on July 7, 2036. After this date, any unexercised options will no longer be exercisable for Seres Therapeutics common stock.